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Abstract
To investigate the reliability of different methods of quantifying retinal ganglion cells (RGCs) in rat retinal sections and
wholemounts from eyes with either intact optic nerves or those axotomised after optic nerve crush (ONC). Adult rats
received a unilateral ONC and after 21 days the numbers of Brn3a+, bIII-tubulin+ and Islet-1+ RGCs were quantified in either
retinal radial sections or wholemounts in which FluoroGold (FG) was injected 48 h before harvesting. Phenotypic antibody
markers were used to distinguish RGCs from astrocytes, macrophages/microglia and amacrine cells. In wholemounted
retinae, counts of FG+ and Brn3a+ RGCs were of similar magnitude in eyes with intact optic nerves and were similarly
reduced after ONC. Larger differences in RGC number were detected between intact and ONC groups when images were
taken closer to the optic nerve head. In radial sections, Brn3a did not stain astrocytes, macrophages/microglia or amacrine
cells, whereas bIII-tubulin and Islet-1 did localize to amacrine cells as well as RGCs. The numbers of bIII-tubulin+ RGCs was
greater than Brn3a+ RGCs, both in retinae from eyes with intact optic nerves and eyes 21 days after ONC. Islet-1 staining also
overestimated the number of RGCs compared to Brn3a, but only after ONC. Estimates of RGC loss were similar in Brn3a-
stained radial retinal sections compared to both Brn3a-stained wholemounts and retinal wholemounts in which RGCs were
backfilled with FG, with sections having the added advantage of reducing experimental animal usage.
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Introduction
Retinal ganglion cells (RGCs) populate the ganglion cell layer
(GCL) of the retina, although in some species a few are found in
the inner nuclear layer (INL; displaced RGCs) [1]. All rat RGC
axons become myelinated at the lamina cribrosa [2,3], project
centripetally in the optic nerve, partially decussate in the chiasma
and synapse in the lateral geniculate body, superior colliculus,
hypothalamus and pretectal area [3]; a few non-/thinly-myelin-
ated peptidergic axons course centrifugally in the optic nerve [4].
Accurate estimates of the total number of RGCs are compromised
by counting errors engendered by: (1), the presence of astrocytes
and displaced amacrine cells, estimated to contribute up to 50% of
cells in the GCL [5,6] and which co-localize with many markers
used to identify RGCs [7–9]; (2), RGCs displaced into the INL [1];
and (3), a progressive decrement in RGC density from the centre
of the retina to the periphery [10].
Techniques aimed at overcoming these confounding issues
include: (1), use of optimal detection and sampling methods; (2),
counting myelinated RGC axons in the optic nerve; (3), using
phenotypic antibody markers with exclusive affinity for RGCs; (4),
transfecting RGCs with green fluorescent protein under control of
the Thy-1 promoter; and (5), back filling exclusively RGCs with
retrogradely transported axon tracers such as FluoroGold (FG)
injected into an optic nerve or both superior colliculi, for which
98% of RGC project to [3,11–13]. The precision of estimates of
total RGC numbers from either retinal sections or wholemounts
relies on the sampling method used. In wholemounts, the location
of standard sampling areas along superior, inferior, temporal and
nasal radii is designed to account for declining RGC/mm2 at
increasing radial distances. In retinal sections, sampling of RGC/
mm over a standard length of the GCL in matching sections
between animals is required and consistency is best achieved by
counting RGCs in radial retinal sections through the optic nerve
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head. For wholemounts, total absolute counts of RGC number is
possible [10] yet may be erroneous if calculated from samples in
which the spatial differences in RGC density are not taken into
account when correcting for total retinal area, or if the retina is not
dissected accurately. Nonetheless, in RGC viability studies it is
generally accepted that retinal wholemount and sectional quan-
titative data give acceptable estimates of percentage differences in
RGC numbers between treatment and control groups.
Myelinated axon counts from the optic nerve yield good
estimates of the total number of RGCs in the retina [14], but
monoaminergic small diameter efferent axons with thin myelin
sheaths [4] are difficult to differentiate from the axons of small
RGCs and thus total myelinated axon counts overestimate RGC
frequency. The use of antibody phenotypic markers to identify
RGCs, such as bIII-tubulin [15,16], Islet-1 [7], Thy-1 [17] and
Brn3a [18] is critically dependant on antibody specificity. Thy-1 is
down-regulated in RGCs in the diseased retina [19] where this
antibody underestimates RGC number and bIII-tubulin and Islet-
1 antibodies both cross-react with ligands expressed by amacrine
cells [7–9,15] which are less likely to die than RGCs after ONC
[20], and thus both antibodies exaggerate RGC survival in cases of
e.g. glaucoma and optic nerve neuritis. By contrast, Brn3a
exclusively stains RGCs by binding to a RGC specific nuclear
epitope [18] with some exceptions such as the intrinsically
photosensitive RGC that are found to be Brn3a- [21]. Transfec-
tion of RGCs with the green fluorescent protein gene (gfp), using
the Thy-1 promoter is a function of transfection efficiency and the
number of cells labelled is rarely absolute, e.g. intravitreal injected
adeno-assosciated virus (AAV) vectors transfect ,85% RGCs
[22].
Back filling all RGCs with FG requires either bilateral injection
into the superior colliculi to capture both contralateral and
ipsilateral RGC projections [11,23], or unilateral injection into the
optic nerve [3,24]. The technique has the potential drawbacks of:
(1), gap junctional transfer of tracer between coupled cells in the
GCL [12] (although transfer takes significantly longer into
amacrine cells than into RGCs); (2), incomplete uptake of tracer
by RGC axons at the site of injection; (3), possible toxicity [25]; (4),
erroneous counting of tracer-filled macrophages/microglia which
have phagocytised dying/dead FG+ RGC [26]; and (5), the lack of
persistence of FG in neuronal cytoplasm [27], including RGCs 3
weeks after administration to the superior colliculus [11]. Since
2.5–4.2% of albino/hooded rat RGC axons project ipsilaterally to
the superior colliculus [21], respectively, FG retrograde transport
after injection of one superior colliculus underestimates RGC
numbers in the contralateral retina in this species [28].
Another disadvantage of labelling RGCs with FG in retinal
whole mount analysis is that the entire retina and optic nerve are
used to generate the labelled cells leaving no tissue for extending
the analysis to include correlative axon counts in the optic nerve
and wider cellular and molecular evaluations of treatments,
making retinal section analysis more efficient both in terms of
data acquisition and animal usage [7,9,24]. However, it is not
clear how reliable counting RGCs in retinal sections is compared
to wholemounts where a much larger sample of the retina is
analysed.
The present study aimed to define and compare the reliability of
RGC counting methods including FG RGC back-filling and
immuno-staining with the commonly used phenotypic markers
bIII-tubulin, Islet-1 and Brn3a in rat retinal wholemounts and
radial sections to determine the most reliable estimates of RGC
loss after induction of RGC death by ONC.
Materials and Methods
All reagents were purchased from Sigma (Poole, UK) unless
otherwise specified.
Experimental design
The left optic nerve in a total of 12 rats was crushed (ONC), the
right optic nerve remained intact (controls). Animals were
separated into 2 groups (Table 1), each of 6 rats, which were all
euthanized on day 21 after ONC. In Group 1, FG was injected
into the proximal segment of both optic nerves of each rat at day
19 and, 48 h later, FG back-filled RGCs, along with Brn3a-stained
RGCs were counted in retinal whole mounts. Group 1 comprised
retinae from right eyes with an intact optic nerve (Group 1a) and
retinae from left eyes that received an ONC (Group 1b). In Group
2, bIII-tubulin-, Islet-1- and Brn3a-stained RGCs were counted in
radial sections of the retinae through the optic disk and double
stained for astrocytes using glial fibrillary acidic protein (GFAP)
amacrine cells using syntaxin-1 [29,30], and macrophages/
microglia using ED1 (Table 2). Group 2 comprised retinae from
right eyes with an intact optic nerve (Group 2a) and retinae from
left eyes that received an ONC (Group 2b).
Animals
All animal procedures were performed in strict accordance to
the UK Home Office Animals Scientific Procedures Act, 1986 and
approved by the University of Birmingham Ethical Review Sub-
Committee. Twelve adult female Sprague Dawley rats weighing
150–200 g (8–10 weeks; Charles River, Kent, UK) were housed in
conditions of 21uC and 55% humidity under a 12 h light and dark
cycle, given food/water ad libitum and supervised constantly by
trained staff. Anaesthesia was induced with 5% Isoflurane/1.5l per
min O2 (National Veterinary Supplies, Stoke, UK) and main-
tained at 3.5% during surgery.
Surgical procedures
After anaesthetic induction as described above and a subcuta-
neous injection of buprenorphine (0.1 ml/100 g; National Veter-
inary Supplies) animals were secured in a head-holding frame.
Intraorbital left ONC was performed in Group 1b and 2b 8–10
week old rats as described previously [31]. Briefly, the optic nerve
was exposed and crushed using forceps 1 mm posterior to the
lamina cribrosa, completely closed around the optic nerve for 5
seconds, without damaging the central retinal artery (confirmed by
lack of ischemia in eyes 7–21 days after ONC). After surgery,
animals were placed in warmed (30uC) recovery cages and closely
monitored until the return of normal behaviour, when they were
transferred to home cages. Two days before tissue harvest, all
Group 1 animals were re-anaesthetised and the optic nerves re-
exposed as above and 2 ml of 4% FG solution (Biotium, Hayward,
CA) in sterile phosphate-buffered saline (PBS) was injected directly
into the right and left nerves distal to the lamina cribrosa (proximal
to the crush site in the left optic nerves in Group 1b), using a glass
micropipette, produced in-house from a glass capillary rod
(Harvard Apparatus, Kent, UK) using a Flaming-Brown micro-
pipette puller (Sutter Instruments, Novato, CA). The injected FG
is incorporated into axons and retrogradely transported axonally
to RGC somata.
Tissue preparation
Group 1 rats were euthanized at 21 days by rising concentration
of CO2. After removal of the cornea and lens, the residual eye cups
were immersion fixed in 4% paraformaldehyde (PFA; TAAB,
Reading, UK) in PBS for 2 h at 4uC before the retinae were
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removed and flattened onto Superfrost glass slides (Superfrost Plus,
Fisher Scientific, Pittsburgh, PA) facilitated by 4 equidistant radial
cuts into the peripheral retina. Wholemounts were immunohisto-
chemically stained immediately at room temperature.
Group 2 rats were euthanized at 21 days by rising concentration
of CO2 and perfused intracardially with 4% PFA in PBS. Eyes
were dissected and immersion fixed in 4% PFA in PBS for 2 h at
4uC and cryoprotected by sequential immersion in 10%, 20% and
30% sucrose solution in PBS, each for 24 h with storage at 4uC.
Eyes were orientated to permit radial sectioning and embedded
using optimal cutting temperature embedding medium (Thermo
Shandon, Runcorn, UK) in peel-away moulds (Agar Scientific,
Essex, UK) by rapid freezing under crushed dry ice and stored at
280uC. Eyes were sectioned radially on a cryostat microtome
(Bright, Huntingdon, UK) at 222uC at a thickness of 20 mm and
sections mounted on positively charged glass slides. Radial eye
sections containing the optic disk and thus sectioned at a consistent
axis were utilized for subsequent analysis. Sections were stored at
220Cu.
Immunohistochemistry
Wholemounted retinae from Group 1 rats were permeabilized
in 0.5% Triton x-100 in PBS for 15 min at 270uC before washing
with room temperature 0.5% Triton x-100 for a further 15 min.
Retinae were incubated with primary antibodies diluted in
wholemount antibody diluting buffer (wADB; 2% bovine serum
albumin, 2% Triton x-100 in PBS) overnight at 4uC and, the
following day, were washed 3610 min in PBS and incubated with
secondary antibodies in wADB for 2 h at room temperature. After
2 h, retinae were washed for 3610 min in PBS and mounted with
the GCL uppermost on glass slides. Slides were allowed to air dry
before mounting in Vectorshield medium (Vector Laboratories,
Peterborough, UK) and applying cover slips. The antibodies used
in this staining are detailed in Table 2.
Mounted radial retinal sections through the optic nerve head
from Group 2 rats were equilibrated to room temperature,
hydrated in PBS for 265 min, permeabilized in 0.1% Triton x-
100 in PBS for 20 min at room temperature and washed for
265 min in PBS before encircling with a hydrophobic PAP pen
(Immedge pen; Vector Laboratories). Non-specific protein binding
sites were blocked by incubating sections in blocking buffer (75 ml;
0.5% bovine serum albumin (g/ml), 0.3% Tween-20, 15% normal
goat/donkey serum (Vector Laboratories) in PBS) in a humidified
chamber for 30 min at room temperature, drained and incubated
with primary antibodies diluted in antibody diluting buffer (ADB;
0.5% bovine serum albumin, 0.3% Tween-20 in PBS) overnight at
4uC. The following day, retinal sections were washed for 365 min
in PBS and incubated with secondary antibodies diluted in ADB
for 1 h in a hydrated incubation chamber at room temperature
and then washed for 365 min in PBS, mounted in Vectorshield
mounting medium containing DAPI (Vector Laboratories) and
stored at 4uC before microscopic analysis. The antibodies used in
this staining are detailed in Table 2. Omission of primary antibody
was used as a staining control.
Microscopy and analysis
For Group 1 retinal wholemounts, images were photographed
from 3 different regions from each retinal quadrant (as detailed in
Fig. 1) using a Zeiss Axioplan-2 fluorescent microscope (Carl
Zeiss, Ltd., Hertfordshire, UK). Images were captured at 200X
magnification using an Axiocam HRc camera (Carl Zeiss, Ltd.)
and all images equivalently contrast enhanced using Photoshop
CS3 (Adobe Systems, Inc., San Jose, CA). The experimenter was
blinded to treatment group and retinal region during counting of
total numbers of Brn3a+ and FG+ cells (total = 3 counts/quadrant,
Table 1. Animal grouping.
Group 1 (6 rats) RGC counted in wholemounted retinae Intact optic nerve Group 1a (6 eyes)
Optic nerve crush Group 1b (6 eyes)
Group 2 (6 rats) RGC counted in radial retinal sections Intact optic nerve Group 2a (6 eyes)
Optic nerve crush Group 2b (6 eyes)
doi:10.1371/journal.pone.0110612.t001
Table 2. Antibodies used in immunohistochemistry.
Antigen Specificity Host species Dilution Supplier Catalogue no.
bIII-tubulin (sections) Monoclonal Mouse 1:500 Sigma #T8660
Brn3a (sections) Polyclonal Goat 1:200 Santa Cruz (Santa Cruz, CA) #SC-31984
Islet-1 (sections & wholemounts) Polyclonal Rabbit 1:200 Abcam (Cambridge, UK) #ab20670
Brn3a (wholemounts) Polyclonal Goat 1:100 Santa Cruz (Santa Cruz, CA) #SC-31984
Syntaxin-1 Monoclonal Mouse 1:200 Abcam #ab3265
GFAP Monoclonal Mouse 1:200 Sigma #G3893
ED1 Monoclonal Mouse 1:200 Serotec (Oxford, UK) #MCA341R
Mouse IgG (Fluor 488) Polyclonal Donkey 1:400 Molecular probes (Paisley, UK) #A-21202
Rabbit IgG (Fluor 488) Polyclonal Donkey 1:400 Molecular Probes #A-21206
Rabbit IgG (Fluor 594) Polyclonal Donkey 1:400 Molecular Probes #A-21207
Goat IgG (Fluor 594) Polyclonal Donkey 1:400 Molecular Probes #A-11058
doi:10.1371/journal.pone.0110612.t002
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12 counts/retina and 6 retinae from 6 different animals per
treatment group) observed in each 0.260 mm2 imaged area. The
mean number of RGCs/image was calculated from a mean count
at each of the 3 radial distances as well as a mean composite count
over all 3 distances.
For Group 2 retinal sections, images were photographed as
detailed above and analysed by an operator blinded to treatment
groups. Brn3a+, bIII-tubulin+ and Islet-1+ RGCs were counted in
20 mm-thick radial sections of the retina, along a 250 mm linear
region of the GCL, either side of the optic nerve head (Fig. 1).
Four sections/retina and 6 retinae from 6 different animals per
treatment group were quantified. As sectioned tissue inevitably
included split RGC nuclei, these were only included in the counts
if the sizes of Brn3a+//Islet-1+ stained nuclei were similar to the
co-localised DAPI+ nuclei. Changes in soma/nuclear size have not
been reported after ONC [32], therefore, although this technique
would be ineffective at calculating absolute RGC numbers, any
inaccuracies would apply equally to both conditions and thus
would not impede reliable comparisons of RGC loss between
groups.
Statistics
All statistical tests were performed using SPSS 17.0 (IBMM
SPSS, Inc., Chicago, IL) and data were presented as mean 6
standard error of the mean (SEM). The Shapiro-Wilk test was used
to ensure all data were normally distributed before applying a one-
way analysis of variance (ANOVA) with a Tukey post-hoc test.
Statistical differences were considered significant at p values ,
0.05.
At the end of the study, a power calculation was performed to
determine the required optimal animal numbers per treatment
group for animal Group 1 and 2. Power calculations were
Figure 1. Sampling method for the counting of RGCs in Group 1 wholemounts (A) and Group 2 tissue sections (B). RGC counts in
retinal wholemounts were made in sampling boxes (0.260 mm2) along quadrant radii at 1.5 mm, 2.5 mm and 3.5 mm from the optic nerve head
(white boxes; A). RGCs were counted in sections over 250 mm length regions at a 200–300 mm distance from the centre of the optic nerve in radial
retinal sections (white lines; B). For panel A, Brn3a (red) was used to stain the retinal wholemount and RGCs (scale bar: 1 mm). For panel B, Brn3a
(green) was used to stain RGCs, GFAP (red) to stain glia and DAPI (blue) was used as a nucleus stain (scale bar: 250 mm).
doi:10.1371/journal.pone.0110612.g001
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performed using G*Power [33] with the following parameters: a
error probability (P value) of 0.05, power (1 - b error probability)
of 0.95 and effect size of 1.32, 2.77 and 7.64 which relates to 10%,
20% and 50% RGC death (as determined by the program)
respectively compared to intact counts of 17.83 RGC/250 mm of
retina.
Results
Group 1 rats
FG+/Brn3a+ RGCs in retinal wholemounts. In the retinae
of Group 1a eyes (intact optic nerve), mean numbers/mm2 of
Brn3a+ and FG+ RGCs were 869.7630.6 and 971.7667.0,
respectively (Fig. 2). In the retinae of Group 1b eyes (21 days after
ONC), mean numbers/mm2 of Brn3a+ and FG+ RGCs were
significantly reduced (P,0.05) compared to Group 1a values
(83.8615.0 and 100.9613.8, respectively). In Group1a retinae,
the density of RGCs decreased towards the periphery, reflected by
a mean number/mm2 of 1073.1621.9, 926.1639.5 and
644.7669.1 Brn3a+ RGCs and 1209.9675.0, 1036.4673.3 and
629.0635.3 FG+ RGCs at 1.5 mm, 2.5 mm and 3.5 mm from the
centre of the optic nerve, respectively. RGC number was
significantly less (P,0.05) in Group 1b retinae compared to
Group 1a retinae with mean counts of 92.9619.9, 79.3615.5,
79.2611.3 Brn3a+ RGCs and 119.1617.3, 95.8615.6,
88.1610.3 FG+ RGCs at 1.5 mm, 2.5 mm and 3.5 mm from
the centre of the retina, respectively.
FG/Brn3a double staining in retinal wholemounts of
Group 1a. In the retinae of Group 1a eyes (intact optic nerve),
quantification of RGCs double staining for Brn3a and FG
revealed that 2.060.15% of Brn3a+ RGCs were FG- and
12.160.7% of FG+ RGCs were Brn3a-. These data confirm that
Brn3a is a specific marker of RGCs.
Group 2 rats
Brn3a+, bIII-tubulin+ and Islet-1+ RGCs in radial retinal
sections. The somata, dendrites and axons of RGCs were
stained with bIII-tubulin in the GCL, inner plexiform layer and
nerve fibre layer, respectively, and Islet-1-stained nuclei were
present in the GCL as well as in the INL, whilst Brn3a exclusively
stained RGC nuclei in the GCL.
In Group 2a retinae (intact optic nerve), the numbers/mm of
Brn3a+, Islet-1+ and bIII-tubulin+ RGCs in the GCL were
71.362.2, 72.361.8 and 83.661.9, respectively (Fig. 3). In Group
2b retinae (21 days after ONC), the numbers/mm of Brn3a+, Islet-
1+ and bIII-tubulin+ RGCs in the GCL were 6.760.7, 17.061.3
and 27.460.9, respectively; which were all significantly different
(P,0.001) from the respective Group 2a counts (Fig. 3).
The number of bIII-tubulin+ RGCs counted in the GCL was
significantly reduced (P,0.001) in Group 2b retinae when
compared to Group 2a retinae, but remained significantly higher
(P,0.05) than the number of either Islet-1+ or Brn3a+ RGCs in
the GCL of Group 2b retinae. Similarly, the number of Islet-1+
RGCs in the GCL was significantly reduced 21 days after ONC,
but the number was significantly higher (P,0.05) than the number
of Brn3a+ RGCs counted in the GCL after ONC. These data
demonstrate that bIII-tubulin and Islet-1 overestimate RGC
numbers.
Co-localization of Brn3a+, bIII-tubulin+ and Islet-1+ RGCs
with GFAP, Syntaxin-1 and ED1 in radial retinal
sections. GFAP+ astrocytes were a distinct population of cells
in the GCL that did not stain with Brn3a, Islet-1 or bIII-tubulin.
Syntaxin-1+ amacrine cells in the INL and GCL were Brn3a-,
although some were Islet-1+ and bIII-tubulin+ (Fig. 4). ED1+
stained sparsely distributed macrophages/microglia throughout
Group 2a retinae, which did not stain with Brn3a-, Islet-1- or bIII-
tubulin. These data suggest that the overestimation of RGC
numbers by bIII-tubulin and Islet-1 staining is due to the staining
and subsequent counting of amacrine cells displaced into the
GCL.
Group 1 and 2 rats
Estimates of RGC death were similar in Group 1 Brn3a/
FG-stained retinal wholemounts and Group 2 Brn3a-stained
radial sections. In Group 2 radial retinal sections, the
percentage death of Islet-1+/bIII-tubulin+ RGC detected was
76.561.5% and 67.061.6%, respectively, which was significantly
lower (P,0.05) than that revealed by Brn3a staining (90.660.9%)
Figure 2. Brn3a+ and FG+ RGC counts in Group 1 whole-
mounted retinae. Immunohistochemically stained wholemounted
retina, stained for Brn3a (red; Ai and Aii) and FG (gold; Aiii and Aiv;
photographs taken in the same field, respectively), taken from Group 1a
animals (intact optic nerve; Ai and Aiii) and Group 1b animals (21 days
after ONC; Aii and Aiv). All images are representative of the 12 images
taken per retina from 6 different animals (scale bar: 50 mm). In (B), the
mean number of Brn3a+ and FG+ RGCs in a 1 mm2 region, from Group
1a and Group 1b rats, calculated as an composite average of 12 images,
or an average of 4 images taken at 1.5 mm, 2.5 mm and 3.5 mm from
the optic nerve head. Asterisks indicate significant difference at p,0.01
between the ONC counts and their respective Group1a controls.
doi:10.1371/journal.pone.0110612.g002
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as well as that estimated after Brn3a/FG staining of retinal
wholemounts (90.261.8% and 89.361.6%, respectively; Fig. 5).
These data show that Brn3a-stained radial sections report the
same percentage RGC death as Brn3a-/FG-stained wholemounts
demonstrating that both techniques reliably quantify RGC loss. In
contrast, Islet-1-/bIII-tubulin-stained radial sections overestimate
the number of surviving RGCs after ONC and thus underestimate
the percentage of RGC loss.
Brn3a-stained Group 1 wholemounts and Group 2 radial
sections detect as low as 10% RGC death. Using data
derived from this experiment, a power calculation was performed
to determine that, in order to detect 50% RGC death at P,0.05, 3
animals/group are required, to detect 20% RGC death at P,
0.05, 5 animals/group are required and to detect 10% RGC death
at P,0.05, 16 animals/group are required. These data suggest
that even as low as 20% RGC death can be detected in radial
stained sections with acceptable animal numbers.
Discussion
Reliable measures of percentage RGC survival in experimental
degenerative retinal conditions including glaucoma [34] and optic
nerve neuropathies [35] are essential to evaluate the efficacy of
novel therapeutic agents designed to treat these disorders.
Pertinent to this is the identification of good phenotypic markers
for RGCs. This study provides evidence that, in determining
percentage RGC loss in rats, estimates from radial sections of
retinae are similar to estimates from wholemounted retinae.
Furthermore, the data reinforce the notion that Brn3a antibodies
are the most reliable phenotypic markers of RGCs both in
wholemounts and sections, whereas bIII-tubulin and Islet-1
antibodies stain amacrine cells in the GCL, giving underestimates
of RGC loss.
Our findings that Brn3a antibodies and FG tracer label
statistically similar numbers of RGCs in wholemounted retinae,
both before and after ONC-induced RGC death are consistent
with the reported 95% co-localization of Brn3a and FG staining in
RGCs [18], further emphasising the utility of Brn3a antibodies as
a reliable RGC marker. The percentage of Brn3a+ cells that were
FG- was 2.0%, which is comparable to the 4.4% previously
reported [18]. FG, a weak base, freely diffuses into intracellular
vesicles where it raises the pH, making the vesicle impermeable,
trapping the FG within; the vesicle is then transported along the
cytoskeleton of the axon [36]. A likely explanation for the presence
of FG-Brn3a+ RGCs is that FG uptake into RGC axons is 98%
efficient. In this study the percentage of FG+ cells that were Brn3a-
was 12.1%, slightly more than the 3.4% previously reported [18],
a figure that is probably explained by the exclusion of FG+/Brn3a-
macrophages/microglia from the data in the Nadal-Nicolas study.
By contrast, in the present study, all cells that were positive for
their respective phenotypic markers were counted and included
and thus we can postulate (but not be certain) that a small
proportion of these FG+ cells were macrophages/microglia. In
Figure 2, FG+ and Brn3a+ images were taken in the same field but
co-localization appears reduced after ONC, likely due to surviving
FG+/Brn3a- macrophages the frequency of which is increased
after RGC death. Although RGC number decreased with
increasing distance from the optic nerve head (1.5 mm, 2.5 mm
and 3.5 mm), the number of RGCs surviving after ONC did not
change with distance (Fig. 2B.), and thus counts closest to the optic
nerve head yielded the biggest relative differences. This is
explained by the homogenous RGC death occurring after
axotomy/ONC [10] whereas the sectorial death seen in laser-
induced ocular hypertension models of glaucoma [37–40] requires
sampling from multiple distances to ensure accuracy in determin-
ing the extent of RGC loss. The counts made from 4 and 12
images had similar SEM, revealing the strength of the sampling
method.
One limitation of this study is that eyes with intact optic nerves
(Group 1a, 2a) contralateral to the ONC eyes (Group 1b, 2b) were
used as controls. It has previously been shown that ocular
hypertension induces microglia activation in eyes contralateral to
the injury [41] as well as a decrease in astrocytes and activation of
Mu¨ller cells [42], with these results partially replicated for
unilateral ONC [43]. However, these changes have not been
correlated with RGC number [42] and equally, the RGC loss
observed in our study 21 days after ONC (when compared to
contralateral eyes) is equivalent to losses reported in the published
literature [3,35,44] leading us to assume that any contralateral
effects instigated by the unilateral ONC had negligible effects on
RGC numbers. An added value of contralateral eye counts is the
resulting reduction in animal usage.
In wholemounted Group 1 retinae, Brn3a is preferred to FG as
a RGC marker, since FG delivery into the optic nerve for
retrograde transport to RGC somata requires further surgery
under anaesthesia. Counts of RGCs with 4 sampling areas each
1.5 mm from the optic nerve head gave reliable estimates of RGC
number in which SEM values where similar to when 12 images/
samples were used. In wholemounts, bIII-tubulin-stained axons
and dendrites which obscured many RGCs, leading to their
exclusion from the count (Fig. S1). In Islet-1-stained wholemounts,
Figure 3. Brn3a+, Islet-1+ and bIII-tubulin+ RGC counts in Group
2 radial retinal sections from Group 2a eyes (intact optic
nerves) and Group 2b eyes (21 days after ONC). Immunohisto-
chemically stained 20-mm-thick radial sections of retina through the
optic nerve head, stained for bIII-tubulin (green; Ai and Aii) or Brn3a
(green) and Islet-1 (red; Aiii and Aiv), taken from Group 2a eyes (Ai and
Aiii) and Group 2b eyes (Aii and Aiv) with the ganglion cell layer (GCL)
labelled. All images are representative of the two images/section, four
sections/retina, and six retinae prepared from six different animals/
group. DAPI was used as a nucleus stain (scale bar: 15 mm). In (B), the
number of Brn3a+, Islet-1+ and bIII-tubulin+ cells, in a 1 mm linear
region of the GCL from Group 2a/2b eyes. Asterisks indicate significant
difference at p,0.05 between groups (ONC and intact) and black lines
indicate significant difference at p,0.05 within groups.
doi:10.1371/journal.pone.0110612.g003
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the high background staining of the INL (Fig. S1) made RGC
counting difficult and excluded consistent 4-image sampling of
some retinae.
Retinal wholemounts restricts the use of the retina to a limited
number of antibody stains [45] and renders the tissue unusable for
further analysis, such as evaluating the effects of treatments on
other proteins and cells as well as retrieving morphological data
such as retinal detachment or the location of grafted cells. By
contrast, radial sections allow all of these data to be obtained from
multiple sections from the same eyes with no loss of fidelity in
RGC quantification. Of note, the homogenous and diffuse loss of
RGCs seen after ONC/axotomy [10] makes sampling around the
optic nerve head in sections a reliable estimate of RGC loss,
whereas in models such as glaucoma where the loss is sectorial
[37–40], expanded sampling is required to include sections
throughout the eye, counting in regions at multiple distances
from the optic nerve head.
We tested Brn3a [18,24], Islet-1 and bIII-tubulin [7,9,24] as
presumptive phenotypic RGC markers. Compared to Brn3a, bIII-
tubulin-stained significantly more cells in the GCL both before
and after ONC-induced RGC death, which we and others [8]
interpret as being due to labelling of amacrine cells in addition to
RGCs. Thus this antibody over estimates the numbers of RGCs
both in Group 1a/2a animals (intact optic nerve) and even more
so in Group 1b/2b animals (21 days after ONC) where the ratio of
Figure 4. Expression of Brn3a, Islet-1 and bIII-tubulin in radial retinal sections and co-localisation of staining for the astrocyte
marker GFAP, the amacrine cell marker Syntaxin-1 and the macrophage/microglia marker ED1. Immunohistochemically stained 20-mm-
thick radial sections of retina, stained for Brn3a (green; Ai, Aiv and Avii), Islet-1 (green; Aii, Av and Aviii), bIII-tubulin (green; Aiii, Avi and Aix), GFAP
(red; Ai, Aii and Aiii), Syntaxin-1 (red; Aiv, Av and Avi) and ED1 (red; Avii, Aviii and Aix), taken from Group 2a eyes (intact optic nerve), with the
outer nuclear layer (ONL), inner nuclear layer (INL) and ganglion cell layer (GCL) labelled, insert showing higher power image of the GCL. All images
are representative; DAPI (blue) was used as a nucleus stain (scale bar: 50 mm; inset scale bar: 25 mm).
doi:10.1371/journal.pone.0110612.g004
Figure 5. The mean percentage of RGC loss 21 days after ONC
in Group 1 and Group 2 rats. Asterisks indicate significant difference
at P,0.05 compared to Brn3a+ RGCs in sections and Brn3a+/FG+ RGCs in
wholemounts (n = 6).
doi:10.1371/journal.pone.0110612.g005
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amacrine cells to RGCs is increased as RGCs are preferentially
lost [20]. Compared to the Brn3a antibody, the Islet-1-stained
similar numbers of cells before ONC but significantly more after
ONC (although still significantly less than with bIII-tubulin
staining after ONC). Since the Islet-1 antibody stains RGCs and
amacrine cells [9], and more displaced amacrine cells survive
relative to RGCs in the GCL 21 days after ONC [20], Islet-1
antibody will overestimate RGC numbers in comparison to Brn3a
after ONC-induced RGC death.
To determine if counts from sections are as reliable as from
wholemounts in quantifying RGC death, we compared the
percentage loss of RGCs between all methods used in this study.
The published figures of 90% RGC death 21 days after ONC
[24,35,44] are similar to those seen in this study with Brn3a-/FG-
stained wholemounts and with Brn3a-stained radial retinal
sections, confirming that counts made in retinal sections are as
reliable as those made in retinal wholemounts. Considering both
the small SEM for each mean and the results from our power
calculation, counts from sections and wholemounts have equal
fidelity in determining significant differences between groups with
as low as 20% difference in RGC number, without the need for
significant increases in animal numbers per treatment group.
Conclusions
We conclude that Brn3a antibody staining of radial retinal
sections is a preferred method for estimating RGC frequency
when compared to techniques using retinal wholemounts in rodent
models of ocular disease. The method avoids both the additional
surgery needed for injection of FG and the sacrifice of further
molecular and morphological retinal analysis, potentially reducing
animal usage and associated costs. We show that cell counts from
retinal sections are as reliable as those from retinal wholemounts
and have equivalent fidelity in determining RGC loss between
control and experimental groups.
Supporting Information
Figure S1 Islet-1- and bIII-tubulin-stained whole-
mounted retinae from Group 1a eyes (intact optic
nerve). Immunohistochemically stained wholemounted retina
stained for Islet-1 (green; Ai) or bIII-tubulin (green; Aii), taken
from Group 1a eyes. All images are representative of the 12 images
taken per retina from 6 different animals (scale bar: 50 mm).
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